In conclusion, the down-regulation of COMMD10 results in the inhibition of GC xenograft growth, suppression of DNA damage repair, augmentation of DNA damage, and activation of the ATM-p53 signaling pathway in xenograft tumor tissues. The gene discussed is COMMD10; the disease is neoplasm.